SEC
6 stories related to this topic, newest first.
usembassykyiv / Wikimedia (Public domain)Treasury Secretary Bessent Announces Executive Order Requiring Banks to Collect Customer Citizenship Data
U.S. Treasury Secretary Scott Bessent stated that an executive order requiring banks to collect citizenship information from customers is in process. Bessent, confirmed by the Senate in a 68-29 vote, was selected by President-elect Donald Trump. He will oversee implementation of…
White House / Wikimedia (Public Domain)Hungarian Prime Minister Viktor Orban Concedes Defeat in General Election After 16 Years in Power
Viktor Orban, Hungary's prime minister, conceded defeat in the general election, ending 16 years of rule by his governing party. The opposition secured victory in the vote held on April 12, 2026. The outcome has drawn attention in American politics, with parts of the right expres…
SemaforUS Energy Secretary Sees Aggressive Timeline for Oil Prices to Decline by Summer
US Energy Secretary Chris Wright stated that a decline in oil and gas prices by this summer represents an aggressive timeframe. His comments followed President Donald Trump's remark that gas prices could rise before midterm elections. Separately, Chinese industrial profits rose 1…
Elekes Andor / Wikimedia (CC BY-SA 4.0)Hungarian Opposition Wins Election, Ending 16 Years of Governing Party Rule
The opposition secured victory in Hungary's general election, leading to the concession of defeat by the leader of the ruling Fidesz party after 16 years in power. The outcome marks the end of unbroken rule for the rightwing populist party. Observers note symbolic significance fo…
Diliff / Wikimedia (CC BY 2.5)U.S. Stock Indexes Open Lower on Monday with Mixed Sector Performance
Major U.S. stock indexes declined at the market open on Monday, April 13, 2026. The Dow Jones Industrial Average fell 0.79% to 47,537.73, while the S&P 500 and Nasdaq also posted losses. Goldman Sachs reported first-quarter earnings that exceeded analyst estimates.
StatRevolution Medicines' Daraxonrasib Succeeds in Phase 3 Trial for Pancreatic Cancer
Revolution Medicines announced that its targeted pill daraxonrasib met primary and secondary endpoints in a Phase 3 trial for metastatic pancreatic cancer patients. The drug extended median survival to 13.2 months compared to 6.7 months with chemotherapy and reduced the risk of d…